Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Insulin Market Research Report 2015-2025

  • HEY3759234
  • 104 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.

The global Insulin market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Ultra-short-acting insulin

Short-acting insulin

In effect insulin

Long-acting insulin

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Novartis

Novo Nordisk

Boehringer Ingelheim

Bristol-Myers Squibb

Eli Lilly

MannKind

Sanofi

Merck

Bioton

GEA

Emisphere

Salix Pharmaceuticals

Gan & Lee

Dongbao

United Laboratories (TUL)

Takeda Pharmaceutical Company

Shihuida PHARMA Group

Henan Tian Fang Pharmaceutical

Disha Pharmaceutical Group

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Type 1 diabetes

Type 2 diabetes

Others diabetes

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Insulin Picture

1.1.2 Specifications

Table Product Specifications of Insulin

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Insulin

Table Global Insulin Market by Type, 2011-2022 (USD Million)

1.2.1.1 Ultra-short-acting insulin

Table Ultra-short-acting insulin Overview

1.2.1.2 Short-acting insulin

Table Short-acting insulin Overview

1.2.1.3 In effect insulin

Table In effect insulin Overview

1.2.1.4 Long-acting insulin

Table Long-acting insulin Overview

1.2.2 by Application

Table Application Segment of Insulin

Table Global Insulin Market by Application, 2011-2022 (USD Million)

1.2.2.1 Type 1 diabetes

Table Type 1 diabetes Overview

1.2.2.2 Type 2 diabetes

Table Type 2 diabetes Overview

1.2.2.3 Others diabetes

Table Others diabetes Overview

1.2.3 by Regions

Table Global Insulin Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Insulin

2.2 Upstream

Table Cost of Insulin

Figure Manufacturing Process of Insulin

2.3 Market

2.3.1 SWOT

Figure SWOT of Insulin

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Insulin

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Insulin

3.4 Market Entry

Table Market Entry of Insulin

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Ultra-short-acting insulin Market, 2013-2018

Figure Ultra-short-acting insulin Market Size and Growth, 2015-2019 (USD Million)

Figure Ultra-short-acting insulin Market Size and Growth, 2015-2019 (in Volume)

Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2015-2019

4.1.2 Short-acting insulin Market, 2013-2018

Figure Short-acting insulin Market Size and Growth, 2015-2019 (USD Million)

Figure Short-acting insulin Market Size and Growth, 2015-2019 (in Volume)

Table Short-acting insulin CAGR by Revenue and Volume, 2015-2019

4.1.3 In effect insulin Market, 2013-2018

Figure In effect insulin Market Size and Growth, 2015-2019 (USD Million)

Figure In effect insulin Market Size and Growth, 2015-2019 (in Volume)

Table In effect insulin CAGR by Revenue and Volume, 2015-2019

4.1.4 Long-acting insulin Market, 2013-2018

Figure Long-acting insulin Market Size and Growth, 2015-2019 (USD Million)

Figure Long-acting insulin Market Size and Growth, 2015-2019 (in Volume)

Table Long-acting insulin CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 Ultra-short-acting insulin Market Forecast, 2020-2025

Figure Ultra-short-acting insulin Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Ultra-short-acting insulin Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2012-2024

4.2.2 Short-acting insulin Market Forecast, 2020-2025

Figure Short-acting insulin Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Short-acting insulin Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Short-acting insulin CAGR by Revenue and Volume, 2012-2024

4.2.3 In effect insulin Market Forecast, 2020-2025

Figure In effect insulin Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure In effect insulin Market Estimates and Forecasts, 2020-2025 (in Volume)

Table In effect insulin CAGR by Revenue and Volume, 2012-2024

4.2.4 Long-acting insulin Market Forecast, 2020-2025

Figure Long-acting insulin Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Long-acting insulin Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Long-acting insulin CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Type 1 diabetes Market, 2013-2018

Figure Type 1 diabetes Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Type 1 diabetes CAGR by Revenue and Volume, 2015-2019

5.1.2 Type 2 diabetes Market, 2013-2018

Figure Type 2 diabetes Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Type 2 diabetes CAGR by Revenue and Volume, 2015-2019

5.1.3 Others diabetes Market, 2013-2018

Figure Others diabetes Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Others diabetes CAGR by Revenue and Volume, 2015-2019

5.2 Market Forecast

5.2.1 Type 1 diabetes Market Forecast, 2020-2025

Figure Type 1 diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Type 1 diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Type 1 diabetes CAGR by Revenue and Volume, 2020-2025

5.2.2 Type 2 diabetes Market Forecast, 2020-2025

Figure Type 2 diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Type 2 diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Type 2 diabetes CAGR by Revenue and Volume, 2020-2025

5.2.3 Others diabetes Market Forecast, 2020-2025

Figure Others diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others diabetes CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2015-2019

Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)

Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

6.1.2 North America

6.1.2.1 North America Market, 2015-2019

Figure North America Market Size and Growth, 2015-2019 (USD Million)

Figure North America Market Size and Growth, 2015-2019 (in Volume)

Table North America CAGR by Revenue and Volume, 2015-2019

6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2015-2019

Figure Europe Market Size and Growth, 2015-2019 (USD Million)

Figure Europe Market Size and Growth, 2015-2019 (in Volume)

Table Europe CAGR by Revenue and Volume, 2015-2019

6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

6.1.4 South America

6.1.4.1 South America Market, 2015-2019

Figure South America Market Size and Growth, 2015-2019 (USD Million)

Figure South America Market Size and Growth, 2015-2019 (in Volume)

Table South America CAGR by Revenue and Volume, 2015-2019

6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2015-2019

Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

7.1 Global Market by Vendors

Table Global Insulin Market by Vendors, 2015-2019 (in Volume)

Table Global Insulin Market Share by Vendors, 2015-2019 (USD Million)

Table Global Insulin Market Share by Vendors, 2015-2019 (in Volume)

7.2 Market Concentration

Figure Insulin Market Concentration by Region

7.3 Price & Factors

Table Price Factors List

7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

8.1 Novartis

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.2 Novo Nordisk

Table Novo Nordisk Profile List

Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.3 Boehringer Ingelheim

Table Boehringer Ingelheim Profile List

Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.4 Bristol-Myers Squibb

Table Bristol-Myers Squibb Profile List

Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.5 Eli Lilly

Table Eli Lilly Profile List

Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.6 MannKind

Table MannKind Profile List

Table Microecological Modulator Operating Data of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.7 Sanofi

Table Sanofi Profile List

Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.8 Merck

Table Merck Profile List

Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.9 Bioton

Table Bioton Profile List

Table Microecological Modulator Operating Data of Bioton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.10 GEA

Table GEA Profile List

Table Microecological Modulator Operating Data of GEA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.11 Emisphere

Table Emisphere Profile List

Table Microecological Modulator Operating Data of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.12 Salix Pharmaceuticals

Table Salix Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Salix Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.13 Gan & Lee

Table Gan & Lee Profile List

Table Microecological Modulator Operating Data of Gan & Lee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.14 Dongbao

Table Dongbao Profile List

Table Microecological Modulator Operating Data of Dongbao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.15 United Laboratories (TUL)

Table United Laboratories (TUL) Profile List

Table Microecological Modulator Operating Data of United Laboratories (TUL) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.16 Takeda Pharmaceutical Company

Table Takeda Pharmaceutical Company Profile List

Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.17 Shihuida PHARMA Group

Table Shihuida PHARMA Group Profile List

Table Microecological Modulator Operating Data of Shihuida PHARMA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.18 Henan Tian Fang Pharmaceutical

Table Henan Tian Fang Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Henan Tian Fang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.19 Disha Pharmaceutical Group

Table Disha Pharmaceutical Group Profile List

Table Microecological Modulator Operating Data of Disha Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

List of Table

Table Product Specifications of Insulin

Table Products Segment of Insulin

Table Global Insulin Market by Type, 2011-2022 (USD Million)

Table Ultra-short-acting insulin Overview

Table Short-acting insulin Overview

Table In effect insulin Overview

Table Long-acting insulin Overview

Table Application Segment of Insulin

Table Global Insulin Market by Application, 2011-2022 (USD Million)

Table Type 1 diabetes Overview

Table Type 2 diabetes Overview

Table Others diabetes Overview

Table Global Insulin Market by Region, 2011-2022 (USD Million)

Table Cost of Insulin

Table Market Dynamics

Table Policy of Insulin

Table GDP of Major Countries

Table Technology of Insulin

Table Market Entry of Insulin

Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2015-2019

Table Short-acting insulin CAGR by Revenue and Volume, 2015-2019

Table In effect insulin CAGR by Revenue and Volume, 2015-2019

Table Long-acting insulin CAGR by Revenue and Volume, 2015-2019

Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2012-2024

Table Short-acting insulin CAGR by Revenue and Volume, 2012-2024

Table In effect insulin CAGR by Revenue and Volume, 2012-2024

Table Long-acting insulin CAGR by Revenue and Volume, 2012-2024

Table Type 1 diabetes CAGR by Revenue and Volume, 2015-2019

Table Type 2 diabetes CAGR by Revenue and Volume, 2015-2019

Table Others diabetes CAGR by Revenue and Volume, 2015-2019

Table Type 1 diabetes CAGR by Revenue and Volume, 2020-2025

Table Type 2 diabetes CAGR by Revenue and Volume, 2020-2025

Table Others diabetes CAGR by Revenue and Volume, 2020-2025

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

Table North America CAGR by Revenue and Volume, 2015-2019

Table Europe CAGR by Revenue and Volume, 2015-2019

Table South America CAGR by Revenue and Volume, 2015-2019

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

Table North America CAGR by Revenue and Volume, 2020-2025

Table Europe CAGR by Revenue and Volume, 2020-2025

Table South America CAGR by Revenue and Volume, 2020-2025

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

Table Global Insulin Market by Vendors, 2015-2019 (in Volume)

Table Global Insulin Market Share by Vendors, 2015-2019 (USD Million)

Table Global Insulin Market Share by Vendors, 2015-2019 (in Volume)

Table Price Factors List

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk Profile List

Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Profile List

Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Profile List

Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Profile List

Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MannKind Profile List

Table Microecological Modulator Operating Data of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Profile List

Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Profile List

Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bioton Profile List

Table Microecological Modulator Operating Data of Bioton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GEA Profile List

Table Microecological Modulator Operating Data of GEA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Emisphere Profile List

Table Microecological Modulator Operating Data of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Salix Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Salix Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gan & Lee Profile List

Table Microecological Modulator Operating Data of Gan & Lee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dongbao Profile List

Table Microecological Modulator Operating Data of Dongbao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Laboratories (TUL) Profile List

Table Microecological Modulator Operating Data of United Laboratories (TUL) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharmaceutical Company Profile List

Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shihuida PHARMA Group Profile List

Table Microecological Modulator Operating Data of Shihuida PHARMA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Henan Tian Fang Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Henan Tian Fang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Disha Pharmaceutical Group Profile List

Table Microecological Modulator Operating Data of Disha Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950